Home » Clinical » Medicines Management » Controlled Drugs

Controlled Drugs

Guidance

GMMMG Opioid Resource Pack 
This document brings together a number of resources clinicians can use to support the appropriate use and review of opioids used for chronic pain. The information in this document does not apply to palliative care and end of life care where use of opioids should follow the World Health Organisation (WHO) pain ladder and relevant guidance.
http://gmmmg.nhs.uk/docs/guidance/Final-Opioid-Resource-Pack-Approved-CSB-August-2018.pdf

Resources for GPs Regarding Opioids and Chronic Pain
https://www.ouh.nhs.uk/services/referrals/pain/opioids-chronic-pain.aspx
 

Local services

Change Grow Live. 
Are a charity that supports people to change their lives for the better. They provide help and support to adults, children, young people and families. Their services cover a wide variety of areas including health and wellbeing, substance use, mental health, criminal justice, domestic abuse and homelessness.
https://www.changegrowlive.org
 
 

NHS England Local Area Team

Any incidents/concerns relating to controlled drugs, in any organisation, whether NHS or private,  need to be reported to the NHS England Controlled Drug Accountable Officer within your area. 
Here is the link to the CD reporting tool:
https://www.cdreporting.co.uk
 
CD Accountable Officer 
Karen O'Brien
Tel: 01138255216
karen.obrien1@nhs.net
 
Controlled drugs accountable officers (CDAOs) are responsible for all aspects of controlled drugs management within their organisation.
 
CD Liaison Officer
Mike Beard.
Tel: 07818457518
michael.beard@gmp.pnn.police.uk

CDLO's offer advice on safe storage, auditing, destruction, suspicious activity, internal thefts, forged or stolen prescriptions, as well as current crime trends. 

If Mike is unavailable, please contact the main office on 0161 856 6491 and one of his colleagues (below) will be able to advise you.
Stefan.Bidolak@gmp.police.uk 
Clive.Jones@gmp.police.uk


Rescheduling of Pregabalin and Gabapentin
The guidance and patient leaflet regarding the rescheduling of pregabalin and gabapentin has been published and can be found here: